CSIMarket
 




Ensysce Biosciences Inc   (ENSC)
Other Ticker:  
 
 



ENSC Price to Sales Ratio (Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Jun 30 2023) (Mar 31 2023)
Sales Trailing 12 Months II. Quarter I. Quarter IV. Quarter II. Quarter I. Quarter
Price to Sales (TTM) Ratio current            1.20            2.13            0.34            1.86            0.66
Revenue TTM Y / Y Change -44.9 % -16.72 % 34.13 % 717.62 % - %
Revenue Y / Y Change -62.93 % -61.28 % -53.19 % 136.41 % - %
Stock performance to date -63.24 % -60.03 % 84.09 % -44.97 % 425.21 %

Price to sales ratio Comment
Company's current Price to sales ratio has decreased due to shareprice contraction of -63.24 %, from beginning of II. Quarter and due to Revenue increase, to Price to Sales of 1.20, from average Price to sales ratio in I. Quarter of 2.13.

Within Healthcare sector 170 other companies have lower Price to sales ratio.

What is Price to Sales Ratio?
Sales growth by Ensysce Biosciences Inc Segment

Price to sales ratio Company Ranking
Within: No.
Industry #61
Sector #171
S&P 500 #1680






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com